HIGHLIGHTS
- who: Xiaoan Ke from the Department of Endocrinology, State Key Laboratory of Complex Severe Shuaifuyuan, PekingBeijing, China have published the Article: The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study, in the Journal: (JOURNAL)
- what: This study explores the incidence and influencing factors of DAs-related side effects in Chinese prolactinoma patients.
- how: The authors conducted this study to investigate specifically the incidence and related factors of side effects associated with psychosocial and physical symptoms in Chinese prolactinoma patients receiving DAs therapy and potentially to provide . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.